Ticker Scorecard - FLGT Basics Company: Fulgent Genetics, Inc. IPO Date: September 29, 2016 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $566.16M Activated in VL: True Average Daily Range Avg Daily Range: $0.96 | 3.01% Avg Daily Range (30 D): $0.30 | 1.53% Avg Daily Range (90 D): $0.35 | 1.73% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 65 Avg Trade Size (Sh.) (30 D): 41 Avg Trade Size (Sh.) (90 D): 41 Institutional Trades Total Inst.Trades: 1,590 Avg Inst. Trade: $1.89M Avg Inst. Trade (30 D): $1.51M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.05M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $.99M Avg Closing Volume: 40.68K     News Jul 3, 2024 @ 12:03 PM Olink® Introduces Global Network of Certified S... Source: N/A May 3, 2024 @ 12:15 PM Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Mis... Source: Zacks Equity Research May 1, 2024 @ 10:00 PM American Well Corporation (AMWL) Reports Q1 Loss, ... Source: Zacks Equity Research Feb 27, 2024 @ 12:25 PM Privia Health (PRVA) Misses Q4 Earnings Estimates Source: Zacks Equity Research Feb 22, 2024 @ 10:25 PM Health Catalyst (HCAT) Q4 Earnings and Revenues Be... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS Diluted EPS Revenue $ 277.76M $ 71.74M $ 71.03M Gross Profit $ 100.6M $ 26.77M $ 26.49M Net Income / Loss $ -171.96M $ -14.69M $ -9.09M Operating Income / Loss $ -208.9M $ -17.08M $ -18.91M Cost of Revenue $ 177.17M $ 44.97M $ 44.54M Net Cash Flow $ -25.9M $ -6.93M $ 10.43M PE Ratio